☆ 4.2 Article

Tauro-Urso-Deoxycholic Acid Trials in Amyotrophic Lateral Sclerosis: What is Achieved and What to Expect

CLINICAL DRUG INVESTIGATION (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Clinical Neurology

Cox regression and survival analysis from the tauro-urso-deoxycholic trial in amyotrophic lateral sclerosis

Giorgio Reggiardo et al.

Summary: Recent phase II pilot clinical trials showed that TUDCA may slow functional decline and increase survival in ALS patients. A multivariate analysis of the original TUDCA cohort demonstrated significant differences in the decline rate and survival time between the active treatment and placebo groups. These findings further support the disease-modifying effect of TUDCA and raise questions about combining it with sodium phenylbutyrate.

FRONTIERS IN NEUROLOGY (2023)

添加到收藏夹

Article Clinical Neurology

Analysis of sodium phenylbutyrate and taurursodiol survival effect in ALS using external controls

Sabrina Paganoni et al.

Summary: This study evaluates the treatment effect of sodium phenylbutyrate and taurursodiol (PB and TURSO) in ALS. The results show that patients treated with PB and TURSO have longer overall survival and lower risk of death compared to placebo. In addition, the analysis with matched external controls provides further evidence of the survival benefit of PB and TURSO in ALS.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2023)

添加到收藏夹

Article Medicine, General & Internal

Effect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a retrospective population-based cohort study

Elisabetta Zucchi et al.

Summary: This study evaluated the survival difference between ALS patients treated with TUDCA and those who received standard care. The results showed that patients treated with TUDCA may have prolonged survival, and the treatment was generally well-tolerated. However, additional prospective randomized studies are needed to confirm the efficacy and safety of this drug.

ECLINICALMEDICINE (2023)

添加到收藏夹

Article Clinical Neurology

Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial

Sabrina Paganoni et al.

Summary: Early use of PB/TURSO can prolong tracheostomy/ventilation-free survival in ALS patients and delay the first hospitalization.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)

添加到收藏夹

Review Clinical Neurology

Review of disease-modifying drug trials in amyotrophic lateral sclerosis

Paolo Tornese et al.

Summary: This study analysed clinical trials of pharmacological interventions on patients with ALS and compared study quality and design features. The findings suggest that functional decline and survival are the reference endpoints, and the primary endpoints included functional assessment, survival, muscle strength, respiratory function, biomarkers, and composite measures. The study also provides cues for the design of future trials.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)

添加到收藏夹

Article Clinical Neurology

Survival analyses from the CENTAUR trial in amyotrophic lateral sclerosis: Evaluating the impact of treatment crossover on outcomes

Sabrina Paganoni et al.

Summary: This study utilized the RPSFTM survival analysis method to analyze data from the CENTAUR trial in ALS, and the results showed a significant survival benefit of PB and TURSO compared to placebo. The findings of this study may contribute to the clinical application of observed survival outcomes in future ALS crossover trials.

MUSCLE & NERVE (2022)

添加到收藏夹

Review Neurosciences

Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases

Kareem Khalaf et al.

Summary: Most neurodegenerative disorders are protein homeostasis diseases, and TUDCA has shown potential therapeutic use in these diseases by exerting anti-apoptotic and neuroprotective activities through various mechanisms.

TRANSLATIONAL NEURODEGENERATION (2022)

添加到收藏夹

Article Clinical Neurology

Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol

Alberto Albanese et al.

Summary: Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disease with limited treatment options, riluzole being the only approved drug in Europe. The TUDCA-ALS trial is a multinational study to evaluate the disease-modifying effects of TUDCA in ALS.

FRONTIERS IN NEUROLOGY (2022)

添加到收藏夹

Article Clinical Neurology

Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis

Sabrina Paganoni et al.

Summary: In the CENTAUR trial for ALS, orally administered PB-TURSO significantly slowed functional decline and a long-term survival analysis showed that participants receiving PB-TURSO treatment had a median survival 6.5 months longer than those on placebo. These results suggest that PB-TURSO has both functional and survival benefits in ALS.

MUSCLE & NERVE (2021)

添加到收藏夹

Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Article Medicine, General & Internal

Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis

Sabrina Paganoni et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Biotechnology & Applied Microbiology

A Stem Cell-Based Screening Platform Identifies Compounds that Desensitize Motor Neurons to Endoplasmic Reticulum Stress

Sebastian Thams et al.

MOLECULAR THERAPY (2019)

添加到收藏夹

Article Clinical Neurology

Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis

A. E. Elia et al.

EUROPEAN JOURNAL OF NEUROLOGY (2016)

添加到收藏夹

Editorial Material Immunology

Post Hoc Analyses

Titte R. Srinivas et al.

TRANSPLANTATION (2015)

添加到收藏夹

Article Medicine, General & Internal

Reporting Discrepancies Between the ClinicalTrials.gov Results Database and Peer-Reviewed Publications

Daniel M. Hartung et al.

ANNALS OF INTERNAL MEDICINE (2014)

添加到收藏夹

Editorial Material Allergy

Post-hoc data analysis: benefits and limitations

Douglas Curran-Everett et al.

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2013)

添加到收藏夹

Article Medicine, General & Internal

Oral Solubilized Ursodeoxycholic Acid Therapy in Amyotrophic Lateral Sclerosis: A Randomized Cross-Over Trial

Ju-Hong Min et al.

JOURNAL OF KOREAN MEDICAL SCIENCE (2012)

添加到收藏夹

Article Clinical Neurology

Phase 2 study of sodium phenylbutyrate in ALS

Merit E. Cudkowicz et al.

AMYOTROPHIC LATERAL SCLEROSIS (2009)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.